KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Endava (DAVA) EBT (2017 - 2025)

Endava's EBT history spans 9 years, with the latest figure at -$9.6 million for Q4 2025.

  • Quarterly EBT fell 399.07% to -$9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 84.67% year-over-year, with the annual reading at $32.2 million for FY2025, 5.54% down from the prior year.
  • EBT came in at -$9.6 million for Q4 2025, up from -$11.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $45.5 million in Q3 2022 to a low of -$11.4 million in Q3 2025.
  • The 5-year median for EBT is $22.3 million (2021), against an average of $18.3 million.
  • The largest YoY upside for EBT was 2652.05% in 2025 against a maximum downside of 399.07% in 2025.
  • Endava's EBT stood at $25.7 million in 2021, then dropped by 7.54% to $23.8 million in 2022, then crashed by 44.64% to $13.2 million in 2023, then plummeted by 75.58% to $3.2 million in 2024, then tumbled by 399.07% to -$9.6 million in 2025.
  • Per Business Quant, the three most recent readings for DAVA's EBT are -$9.6 million (Q4 2025), -$11.4 million (Q3 2025), and $5.1 million (Q2 2025).